• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子降解酶概述。

Overview of PAF-Degrading Enzymes.

作者信息

Karasawa Ken, Inoue Keizo

机构信息

Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan.

Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan.

出版信息

Enzymes. 2015;38:1-22. doi: 10.1016/bs.enz.2015.09.006. Epub 2015 Nov 6.

DOI:10.1016/bs.enz.2015.09.006
PMID:26612643
Abstract

Because the acetyl group of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) is essential for its biological activity, the degradation of PAF is the most important mechanism that regulates the level of PAF. The enzyme that catalyzes the hydrolysis of acetyl group at the sn-2 position of PAF was termed PAF-acetylhydrolase (PAF-AH). Subsequent research revealed that the PAF-AH family includes intracellular forms called PAF-AH I and PAF-AH II as well as an extracellular isoform, plasma PAF-AH. PAF-AH I forms a complex consisting of catalytic subunits α1, α2, and β regulatory subunits. PAF-AH I was identified from the brain, and previous studies focused on the role of PAF-AH I in brain development. However, subsequent studies found that PAF-AH I is involved in diverse functions such as spermatogenesis, amyloid-β generation, cancer pathogenesis, and protein trafficking. Another intracellular enzyme, PAF-AH II, has no homology with PAF-AH I, although this enzyme shares sequence similarity to plasma PAF-AH. Because PAF-AH preferentially hydrolyzes oxidatively modulated or truncated phospholipids, it is considered to play a protective role against oxidative stress. Homologs of this enzyme are widely distributed among evolutionarily diverse organisms. For example, studies of Caenorhabditis elegans PAF-AH II demonstrate its contribution to epidermal morphogenesis. Extracellular plasma PAF-AH associates strongly with plasma lipoproteins. Because PAF-AH is mainly associated with LDL particles, it is considered to play an anti-inflammatory role by removing oxidized phospholipids generated in LDLs exposed to oxidative stress. In this overview, we describe the crucial roles of these three PAF-degrading enzymes in cell function and cell pathology.

摘要

由于1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱(PAF)的乙酰基对其生物活性至关重要,因此PAF的降解是调节PAF水平的最重要机制。催化PAF的sn-2位乙酰基水解的酶被称为PAF-乙酰水解酶(PAF-AH)。随后的研究表明,PAF-AH家族包括细胞内形式的PAF-AH I和PAF-AH II以及细胞外异构体血浆PAF-AH。PAF-AH I形成一个由催化亚基α1、α2和β调节亚基组成的复合物。PAF-AH I是从大脑中鉴定出来的,之前的研究集中在PAF-AH I在大脑发育中的作用。然而,随后的研究发现PAF-AH I参与了多种功能,如精子发生、淀粉样β蛋白生成、癌症发病机制和蛋白质运输。另一种细胞内酶PAF-AH II与PAF-AH I没有同源性,尽管这种酶与血浆PAF-AH具有序列相似性。由于PAF-AH优先水解氧化修饰或截短的磷脂,因此被认为在抗氧化应激中起保护作用。这种酶的同源物在进化上不同的生物体中广泛分布。例如,对秀丽隐杆线虫PAF-AH II的研究证明了它对表皮形态发生的作用。细胞外血浆PAF-AH与血浆脂蛋白强烈结合。由于PAF-AH主要与低密度脂蛋白颗粒相关,因此被认为通过去除暴露于氧化应激的低密度脂蛋白中产生的氧化磷脂发挥抗炎作用。在本综述中,我们描述了这三种PAF降解酶在细胞功能和细胞病理学中的关键作用。

相似文献

1
Overview of PAF-Degrading Enzymes.血小板活化因子降解酶概述。
Enzymes. 2015;38:1-22. doi: 10.1016/bs.enz.2015.09.006. Epub 2015 Nov 6.
2
Platelet-activating factor acetylhydrolase (PAF-AH).血小板活化因子乙酰水解酶(PAF-AH)
J Biochem. 2002 May;131(5):635-40. doi: 10.1093/oxfordjournals.jbchem.a003145.
3
Platelet-activating factor acetylhydrolase.血小板活化因子乙酰水解酶
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:83-94. doi: 10.1016/s0090-6980(02)00023-0.
4
Intracellular Platelet-Activating Factor Acetylhydrolase, Type II: A Unique Cellular Phospholipase A2 That Hydrolyzes Oxidatively Modified Phospholipids.II型细胞内血小板活化因子乙酰水解酶:一种独特的细胞磷脂酶A2,可水解氧化修饰的磷脂。
Enzymes. 2015;38:43-54. doi: 10.1016/bs.enz.2015.09.008. Epub 2015 Oct 20.
5
Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II.细胞内血小板活化因子乙酰水解酶II对氧化应激诱导的细胞死亡的保护作用。
J Biol Chem. 1997 Dec 19;272(51):32315-20. doi: 10.1074/jbc.272.51.32315.
6
A Complex of Type I Platelet-Activating Factor Acetylhydrolase (PAF-AH) Catalytic Subunits Switches from α1/α2 Heterodimer to α2/α2 Homodimer during Adipocyte Differentiation of 3T3-L1 Cells.在3T3-L1细胞脂肪细胞分化过程中,I型血小板活化因子乙酰水解酶(PAF-AH)催化亚基复合物从α1/α2异二聚体转变为α2/α2同二聚体。
Biol Pharm Bull. 2023;46(2):257-262. doi: 10.1248/bpb.b22-00666.
7
Intracellular PAF-Acetylhydrolase Type I.I型细胞内血小板活化因子乙酰水解酶
Enzymes. 2015;38:23-36. doi: 10.1016/bs.enz.2015.09.007. Epub 2015 Nov 4.
8
Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids.血小板激活因子乙酰水解酶 II:一种属于磷脂酶 A2 家族的酶,可水解氧化磷脂。
Chem Phys Lipids. 2021 Sep;239:105103. doi: 10.1016/j.chemphyslip.2021.105103. Epub 2021 Jun 8.
9
Type II platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans.II型血小板活化因子乙酰水解酶对线虫上皮形态发生至关重要。
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13233-8. doi: 10.1073/pnas.0405507101. Epub 2004 Aug 30.
10
Plasma platelet activating factor-acetylhydrolase (PAF-AH).血浆血小板活化因子乙酰水解酶(PAF-AH)。
Prog Lipid Res. 2003 Mar;42(2):93-114. doi: 10.1016/s0163-7827(02)00049-8.

引用本文的文献

1
A pro-metastatic tRNA fragment drives Nucleolin oligomerization and stabilization of its bound metabolic mRNAs.一段促进转移的 tRNA 片段可驱动核仁蛋白寡聚化,并稳定其结合的代谢 mRNA。
Mol Cell. 2022 Jul 21;82(14):2604-2617.e8. doi: 10.1016/j.molcel.2022.05.008. Epub 2022 Jun 1.
2
UVB-Induced Microvesicle Particle Release and Its Effects on the Cutaneous Microenvironment.UVB 诱导的微囊泡粒子释放及其对皮肤微环境的影响。
Front Immunol. 2022 May 6;13:880850. doi: 10.3389/fimmu.2022.880850. eCollection 2022.
3
Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach.
家族性高胆固醇血症患者使用前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂治疗可降低血浆血小板活化因子及其前体水平:代谢组学与脂质组学联合研究方法
Biomedicines. 2021 Aug 23;9(8):1073. doi: 10.3390/biomedicines9081073.
4
The Roles of Phospholipase A in Phagocytes.磷脂酶A在吞噬细胞中的作用。
Front Cell Dev Biol. 2021 Jun 10;9:673502. doi: 10.3389/fcell.2021.673502. eCollection 2021.
5
Switching the substrate specificity of lysoplasmalogen-specific phospholipase D.切换溶酶体磷脂酶 D 对赖氨酸质体的特异性。
FEBS Open Bio. 2021 Apr;11(4):1132-1143. doi: 10.1002/2211-5463.13123. Epub 2021 Mar 19.
6
Plasma Metabolomics Analysis Identifies Abnormal Energy, Lipid, and Amino Acid Metabolism in Abdominal Aortic Aneurysms.血浆代谢组学分析揭示腹主动脉瘤中能量、脂质和氨基酸代谢异常。
Med Sci Monit. 2020 Dec 1;26:e926766. doi: 10.12659/MSM.926766.
7
The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.饮食性血小板激活因子抑制剂在癌症预防和治疗中的潜在作用。
Adv Nutr. 2019 Jan 1;10(1):148-164. doi: 10.1093/advances/nmy090.
8
Inflammation, not Cholesterol, Is a Cause of Chronic Disease.炎症而非胆固醇是慢性病的病因。
Nutrients. 2018 May 12;10(5):604. doi: 10.3390/nu10050604.
9
Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.辅酶A非依赖性转酰基化系统;磷脂酶A2在转酰基化中的可能作用。
Biology (Basel). 2017 Mar 30;6(2):23. doi: 10.3390/biology6020023.